Communicable Disease
COVID Vaccine: How Effective Are They Against Variants?
COVID Vaccine: How Effective Are They Against Variants? …
TAG
May 3, 2022
COVID Vaccine: How Effective Are They Against Variants? …
Key Points: In today’s Recommendations for Industry, we discuss low COVID levels across much of the U.S. with some regional levels of BA.2.12. Read more
Key Points: In today’s Recommendations for Industry, we discuss the dropping of the travel mask mandate. Read more below. Declaring the COVID-19 travel mask mandate
Key Points: In today’s Recommendations for Industry, we discuss the current status of COVID and the conflicting news. Read more below. The CDC has extended
Key Points: In today’s Recommendations for Industry, we discuss the “blip” in U.S. COVID cases, despite the fact that BA.2 has become the dominant variant.
Key Points: In today’s Recommendations for Industry, we discuss the flattening of global COVID cases. Read more below. Asian COVID hot spots show signs of
Key Points: In today’s Recommendations for Industry, we discuss a return to normal. Read more below. In a recent paper published in JAMA Neurology, CIDRAP
Key Points: In today’s Recommendations for Industry, we discuss the impact of the national COVID plans on workforce decision-making. Read more below. White House Releases
Key Points: In today’s Recommendations for Industry, we discuss CDC’s new masking guidance and the utilization of the County-Searchable Tool. Read more below. A recent
Key Points: In today’s Recommendations for Industry, we discuss TAG’s weekly COVID matrix and its indicators for endemic vs. pandemic and related masking requirements. Read
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
